Comorbid mental disorders in substance users from a single catchment area (2024)

1. Albanese MJ, Clodfelter RC, Pardo TB, Ghaemi SN: Underdiagnosis of bipolar disorder in men with substance use disorder. Journal of Psychiatric Practice. 2006, 12: 124-127. 10.1097/00131746-200603000-00010.
   https://doi.org/10.1097/00131746-200603000-00010
2. Ringen PA, Melle I, Birkenaes AB, Engh JA, Faerden A, Vaskinn A, Friis S, Opjordsmoen S, Andreassen OA: The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness. Acta Psychiatr Scand. 2008, 118: 297-304. 10.1111/j.1600-0447.2008.01244.x.
   https://doi.org/10.1111/j.1600-0447.2008.01244.x
3. Verheul R, van den BW, Hartgers C: Personality disorders predict relapse in alcoholic patients. Addict Behav. 1998, 23: 869-882. 10.1016/S0306-4603(98)00065-3.
   https://doi.org/10.1016/S0306-4603(98)00065-3
4. Torrens M, Fonseca F, Mateu G, Farre M: Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug & Alcohol Dependence. 2005, 78: 1-22. [Review] [140 refs]
   https://doi.org/10.1016/j.drugalcdep.2004.09.004
5. Mazza M, Mandelli L, Di NM, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L: Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. J Affect Disord. 2009, 115: 27-35. 10.1016/j.jad.2008.08.019.
   https://doi.org/10.1016/j.jad.2008.08.019
6. Curran GM, Sullivan G, Williams K, Han X, Collins K, Keys J, Kotrla KJ: Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Ann Emerg Med. 2003, 41: 659-667. 10.1067/mem.2003.154.
   https://doi.org/10.1067/mem.2003.154
7. Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ: Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS. 2005, 19 (Suppl-33):
   https://doi.org/10.1097/01.aids.0000192067.94033.aa
8. Cottler LB, Campbell W, Krishna VA, Cunningham-Williams RM, Abdallah AB: Predictors of high rates of suicidal ideation among drug users. Journal of Nervous & Mental Disease. 2005, 193: 431-437.
   https://doi.org/10.1097/01.nmd.0000168245.56563.90
9. Fergusson DM, Horwood LJ, Lynskey MT: The effects of unemployment on psychiatric illness during young adulthood. Psychol Med. 1997, 27: 371-381. 10.1017/S0033291796004412.
   https://doi.org/10.1017/S0033291796004412
10. Caton CL, Shrout PE, Eagle PF, Opler LA, Felix A, Dominguez B: Risk factors for homelessness among schizophrenic men: a case-control study. Am J Public Health. 1994, 84: 265-270. 10.2105/AJPH.84.2.265.
    https://doi.org/10.2105/AJPH.84.2.265
11. Elbogen EB, Johnson SC: The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2009, 66: 152-161. 10.1001/archgenpsychiatry.2008.537.
    https://doi.org/10.1001/archgenpsychiatry.2008.537
12. Goldstein BI, Levitt AJ: The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disorders. 2008, 10: 67-78. 10.1111/j.1399-5618.2008.00461.x.
    https://doi.org/10.1111/j.1399-5618.2008.00461.x
13. Havassy BE, Alvidrez J, Owen KK: Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am J Psychiatry. 2004, 161: 139-145. 10.1176/appi.ajp.161.1.139.
    https://doi.org/10.1176/appi.ajp.161.1.139
14. Brunette MF, Mueser KT: Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder. J Clin Psychiatry. 2006, 67 (Suppl-7): [Review] [59 refs]
15. RachBeisel J, Scott J, Dixon L: Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999, 50: 1427-1434. [Review] [89 refs]
    https://doi.org/10.1176/ps.50.11.1427
16. Moggi F, Brodbeck J, Koltzsch K, Hirsbrunner HP, Bachmann KM: One-year follow-up of dual diagnosis patients attending a 4-month integrated inpatient treatment. Eur Addict Res. 2002, 8: 30-37. 10.1159/000049485.
    https://doi.org/10.1159/000049485
17. Bryant KJ, Rounsaville B, Spitzer RL, Williams JB: Reliability of dual diagnosis. Substance dependence and psychiatric disorders. Journal of Nervous & Mental Disease. 1992, 180: 251-257.
    https://doi.org/10.1097/00005053-199204000-00007
18. Schuckit MA: Comorbidity between substance use disorders and psychiatric conditions. Addiction. 2006, 101 (Suppl-88): [Review] [138 refs]
19. Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL: Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry. 1997, 154: 948-957. [see comment]
    https://doi.org/10.1176/ajp.154.7.948
20. Markou A, Kosten TR, Koob GF: Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 1998, 18: 135-174. 10.1016/S0893-133X(97)00113-9. [Review] [490 refs]
    https://doi.org/10.1016/S0893-133X(97)00113-9
21. Kessler RC, Amminger GP, guilar-Gaxiola S, Alonso J, Lee S, Ustun TB: Age of onset of mental disorders: a review of recent literature. Current Opinion in Psychiatry. 2007, 20: 359-364. 10.1097/YCO.0b013e32816ebc8c. [Review] [50 refs]
    https://doi.org/10.1097/YCO.0b013e32816ebc8c
22. Brown SA, Inaba RK, Gillin JC, Schuckit MA, Stewart MA, Irwin MR: Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry. 1995, 152: 45-52.
    https://doi.org/10.1176/ajp.152.1.45
23. Kadden RM, Kranzler HR, Rounsaville BJ: Validity of the distinction between 'substance-induced' and 'independent' depression and anxiety disorders. American Journal on Addictions 4(2)()(pp 107-117), 1995 Date of Publication: 1995. 1995, 107-117.
24. Verheul R, Kranzler HR, Poling J, Tennen H, Ball S, Rounsaville BJ: Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact?. J Stud Alcohol. 2000, 61: 101-110.
    https://doi.org/10.15288/jsa.2000.61.101
25. Volkow ND, Fowler JS, Wang GJ: Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol. 2002, 13: 355-366. [comment]. [Review] [60 refs]
    https://doi.org/10.1097/00008877-200209000-00008
26. Volkow ND, Fowler JS, Wang GJ, Swanson JM: Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry. 2004, 9: 557-569. 10.1038/sj.mp.4001507. [Review] [114 refs]
    https://doi.org/10.1038/sj.mp.4001507
27. Wise RA: Brain reward circuitry: insights from unsensed incentives. Neuron. 2002, 36: 229-240. 10.1016/S0896-6273(02)00965-0. [Review] [175 refs]
    https://doi.org/10.1016/S0896-6273(02)00965-0
28. Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002, 159: 1642-1652. 10.1176/appi.ajp.159.10.1642. [Review] [103 refs]
    https://doi.org/10.1176/appi.ajp.159.10.1642
29. Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005, 162: 1403-1413. 10.1176/appi.ajp.162.8.1403. [Review] [110 refs]
    https://doi.org/10.1176/appi.ajp.162.8.1403
30. Brady KT, Sinha R: Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry. 2005, 162: 1483-1493. 10.1176/appi.ajp.162.8.1483. [see comment]. [Review] [119 refs]
    https://doi.org/10.1176/appi.ajp.162.8.1483
31. Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M: Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry. 2002, 59: 1039-1044. 10.1001/archpsyc.59.11.1039.
    https://doi.org/10.1001/archpsyc.59.11.1039
32. Volkow ND: What do we know about drug addiction?. Am J Psychiatry. 2005, 162: 1401-1402. 10.1176/appi.ajp.162.8.1401.
    https://doi.org/10.1176/appi.ajp.162.8.1401
33. Hasin DS, Grant BF: Diagnosing depressive disorders in patients with alcohol and drug problems: a comparison of the SADS-L and the DIS. J Psychiatr Res. 1987, 21: 301-311. 10.1016/0022-3956(87)90032-X.
    https://doi.org/10.1016/0022-3956(87)90032-X
34. Hasin DS, Grant BF: Psychiatric diagnosis of patients with substance abuse problems: a comparison of two procedures, the DIS and the SADS-L. Alcoholism, drug abuse/dependence, anxiety disorders and antisocial personality disorder. J Psychiatr Res. 1987, 21: 7-22. 10.1016/0022-3956(87)90005-7.
    https://doi.org/10.1016/0022-3956(87)90005-7
35. Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V: A validity study of the SSAGA--a comparison with the SCAN. Addiction. 1999, 94: 1361-1370. 10.1046/j.1360-0443.1999.94913618.x.
    https://doi.org/10.1046/j.1360-0443.1999.94913618.x
36. Weiss RD, Mirin SM, Griffin ML: Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers. Br J Addict. 1992, 87: 179-187. 10.1111/j.1360-0443.1992.tb02691.x. [Review] [47 refs]
    https://doi.org/10.1111/j.1360-0443.1992.tb02691.x
37. Kranzler HR, Kadden RM, Babor TF, Tennen H, Rounsaville BJ: Validity of the SCID in substance abuse patients. Addiction. 1996, 91: 859-868. 10.1111/j.1360-0443.1996.tb03580.x.
    https://doi.org/10.1111/j.1360-0443.1996.tb03580.x
38. Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ: Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?. Compr Psychiatry. 1995, 36: 278-288. 10.1016/S0010-440X(95)90073-X. [erratum appears in Compr Psychiatry 1995 Sep-Oct;36(5):396]
    https://doi.org/10.1016/S0010-440X(95)90073-X
39. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990, 264: 2511-2518. 10.1001/jama.264.19.2511. [see comment]
    https://doi.org/10.1001/jama.264.19.2511
40. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ: The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996, 66: 17-31. 10.1037/h0080151.
    https://doi.org/10.1037/h0080151
41. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC: Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997, 54: 313-321.
    https://doi.org/10.1001/archpsyc.1997.01830160031005
42. Kringlen E, Torgersen S, Cramer V: A Norwegian psychiatric epidemiological study. Am J Psychiatry. 2001, 158: 1091-1098. 10.1176/appi.ajp.158.7.1091.
    https://doi.org/10.1176/appi.ajp.158.7.1091
43. Kringlen E, Torgersen S, Cramer V: Mental illness in a rural area: a Norwegian psychiatric epidemiological study. Social Psychiatry & Psychiatric Epidemiology. 2006, 41: 713-719.
    https://doi.org/10.1007/s00127-006-0080-0
44. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de GG, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, rbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA, Investigators ESotEoMDEP: Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica, Supplementum. 2004, 21-27.
45. Currie SR, Patten SB, Williams JV, Wang J, Beck CA, el-Guebaly N, Maxwell C: Comorbidity of major depression with substance use disorders. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie. 2005, 50: 660-666.
    https://doi.org/10.1177/070674370505001013
46. de Graaf R, Bijl RV, Ten HM, Beekman AT, Vollebergh WA: Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord. 2004, 82: 461-467. 10.1016/j.jad.2004.03.001.
    https://doi.org/10.1016/j.jad.2004.03.001
47. de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J: Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry. 2002, 159: 620-629. 10.1176/appi.ajp.159.4.620.
    https://doi.org/10.1176/appi.ajp.159.4.620
48. Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, Lewis G, Marsden J, Taylor C, Meltzer H: Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry. 2001, 179: 432-437. 10.1192/bjp.179.5.432.
    https://doi.org/10.1192/bjp.179.5.432
49. Aalto-Setala T, Marttunen M, Tuulio-Henriksson A, Poikolainen K, Lonnqvist J: One-month prevalence of depression and other DSM-IV disorders among young adults. Psychol Med. 2001, 31: 791-801. 10.1017/S0033291701004081.
    https://doi.org/10.1017/S0033291701004081
50. Chong MY, Chan KW, Cheng AT: Substance use disorders among adolescents in Taiwan: prevalence, sociodemographic correlates and psychiatric co-morbidity. Psychol Med. 1999, 29: 1387-1396. 10.1017/S0033291799001257.
    https://doi.org/10.1017/S0033291799001257
51. Pakriev S, Vasar V, Aluoja A, Shlik J: Prevalence of ICD-10 harmful use of alcohol and alcohol dependence among the rural population in Udmurtia. Alcohol & Alcoholism. 1998, 33: 255-264.
    https://doi.org/10.1093/oxfordjournals.alcalc.a008389
52. Ramsey SE, Kahler CW, Read JP, Stuart GL, Brown RA: Discriminating between substance-induced and independent depressive episodes in alcohol dependent patients. Journal of Studies on Alcohol 65(5)()(pp 672-676), 2004 Date of Publication: Sep 2004. 2004, 672-676.
53. Davidson KM: Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status. Br J Psychiatry. 1995, 166: 199-204. 10.1192/bjp.166.2.199.
    https://doi.org/10.1192/bjp.166.2.199
54. Yeh HS, Lee YC, Sun HJ, Wan SR: Six months follow-up of patients with methamphetamine psychosis. Chung Hua i Hsueh Tsa Chih - Chinese Medical Journal. 2001, 64: 388-394.
55. Caton CL, Samet S, Hasin DS: When acute-stage psychosis and substance use co-occur: differentiating substance-induced and primary psychotic disorders. J Psychiatr Pract. 2000, 6: 256-266. 10.1097/00131746-200009000-00003.
    https://doi.org/10.1097/00131746-200009000-00003
56. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J: Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry. 1996, 153: 1195-1201.
    https://doi.org/10.1176/ajp.153.9.1195
57. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N, Ford C, Comorbidity of Substance Misuse and Mental Illness Collaborative study team: Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry. 2003, 183: 304-313. 10.1192/bjp.183.4.304.
    https://doi.org/10.1192/bjp.183.4.304
58. Modestin J, Nussbaumer C, Angst K, Scheidegger P, Hell D: Use of potentially abusive psychotropic substances in psychiatric inpatients. European Archives of Psychiatry & Clinical Neuroscience. 1997, 247: 146-153.
    https://doi.org/10.1007/BF03033068
59. Weaver T, Rutter D, Madden P, Ward J, Stimson G, Renton A: Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Social Psychiatry & Psychiatric Epidemiology. 2001, 36: 399-406.
    https://doi.org/10.1007/s001270170030
60. Cantor-Graae E, Nordstrom LG, McNeil TF: Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res. 2001, 48: 69-82. 10.1016/S0920-9964(00)00114-6. [Review] [83 refs]
    https://doi.org/10.1016/S0920-9964(00)00114-6
61. Cassidy F, Ahearn EP, Carroll BJ: Substance abuse in bipolar disorder. Bipolar Disord. 2001, 3: 181-188. 10.1034/j.1399-5618.2001.30403.x.
    https://doi.org/10.1034/j.1399-5618.2001.30403.x
62. Sbrana A, Bizzarri JV, Rucci P, Gonnelli C, Doria MR, Spagnolli S, Ravani L, Raimondi F, Dell'Osso L, Cassano GB: The spectrum of substance use in mood and anxiety disorders. Compr Psychiatry. 2005, 46: 6-13. 10.1016/j.comppsych.2004.07.017.
    https://doi.org/10.1016/j.comppsych.2004.07.017
63. van den Bosch LM, Verheul R, van den BW: Substance abuse in borderline personality disorder: clinical and etiological correlates. J Personal Disord. 2001, 15: 416-424. 10.1521/pedi.15.5.416.19201.
    https://doi.org/10.1521/pedi.15.5.416.19201
64. Wolfe WL, Maisto SA: The relationship between eating disorders and substance use: moving beyond co-prevalence research. Clin Psychol Rev. 2000, 20: 617-631. 10.1016/S0272-7358(99)00009-4. [Review] [80 refs]
    https://doi.org/10.1016/S0272-7358(99)00009-4
65. Larsen TK, Melle I, Auestad B, Friis S, Haahr U, Johannessen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan TH: Substance abuse in first-episode non-affective psychosis. Schizophr Res. 2006, 88: 55-62. 10.1016/j.schres.2006.07.018.
    https://doi.org/10.1016/j.schres.2006.07.018
66. Helseth V, Lykke-Enger T, Johnsen J, Waal H: Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nordic Journal of Psychiatry 63(1)()(pp 72-77), 2009 Date of Publication: 2009. 2009, 72-77.
67. Gråwe RWRT: Rus og psykiske lidelser i psykisk helsevern for voksne. 2006, SINTEF Helse, Ref Type: Report
68. Hasin DS, Stinson FS, Ogburn E, Grant BF: Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007, 64: 830-842. 10.1001/archpsyc.64.7.830.
    https://doi.org/10.1001/archpsyc.64.7.830
69. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F: Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991, 48: 43-51.
    https://doi.org/10.1001/archpsyc.1991.01810250045005
70. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, guilar-Gaziola S, Bijl R, Borges G, Caraveo-Anduaga JJ, DeWit DJ, Kolody B, Vega WA, Wittchen HU, Kessler RC: Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav. 1998, 23: 893-907. 10.1016/S0306-4603(98)00076-8.
    https://doi.org/10.1016/S0306-4603(98)00076-8
71. Schneider U, Altmann A, Baumann M, Bernzen J, Bertz B, Bimber U, Broese T, Broocks A, Burtscheidt W, Cimander KF, Degkwitz P, Driessen M, Ehrenreich H, Fischbach E, Folkerts H, Frank H, Gurth D, Havemann-Reinecke U, Heber W, Heuer J, Hingsammer A, Jacobs S, Krampe H, Lange W, Lay T, Leimbach M, Lemke MR, Leweke M, Mangholz A, Massing W, Meyenberg R, Porzig J, Quattert T, Redner C, Ritzel G, Rollnik JD, Sauvageoll R, Schlafke D, Schmid G, Schroder H, Schwichtenberg U, Schwoon D, Seifert J, Sickelmann I, Sieveking CF, Spiess C, Stiegemann HH, Stracke R, Straetgen HD, Subkowski P, Thomasius R, Tretzel H, Verner LJ, Vitens J, Wagner T, Weirich S, Weiss I, Wendorff T, Wetterling T, Wiese B, Wittfoot J: Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first Multicentre Study in Germany. Alcohol & Alcoholism. 2001, 36: 219-223.
    https://doi.org/10.1093/alcalc/36.3.219
72. Hannesdottir H, Tyrfingsson T, Piha J: Psychosocial functioning and psychiatric comorbidity among substance-abusing Icelandic adolescents. Nordic Journal of Psychiatry. 2001, 55: 43-48. 10.1080/080394801750093742.
    https://doi.org/10.1080/080394801750093742
73. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M: Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry. 2000, 176: 285-289. 10.1192/bjp.176.3.285. [see comment]
    https://doi.org/10.1192/bjp.176.3.285
74. Adamson SJ, Todd FC, Sellman JD, Huriwai T, Porter J: Coexisting psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population. Australian & New Zealand Journal of Psychiatry. 2006, 40: 164-170.
    https://doi.org/10.1080/j.1440-1614.2006.01764.x
75. Kushner MG, Sher KJ, Beitman BD: The relation between alcohol problems and the anxiety disorders. Am J Psychiatry. 1990, 147: 685-695. [see comment]. [Review] [76 refs]
    https://doi.org/10.1176/ajp.147.6.685
76. Myrick H, Brady KT: Social phobia in cocaine-dependent individuals. Am J Addict. 1997, 6: 99-104.
77. Jacobsen LK, Southwick SM, Kosten TR: Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry. 2001, 158: 1184-1190. 10.1176/appi.ajp.158.8.1184. [Review] [69 refs]
    https://doi.org/10.1176/appi.ajp.158.8.1184
78. Brown SA, Schuckit MA: Changes in depression among abstinent alcoholics. J Stud Alcohol. 1988, 49: 412-417.
    https://doi.org/10.15288/jsa.1988.49.412
79. Verheul R: Co-morbidity of personality disorders in individuals with substance use disorders. European Psychiatry: the Journal of the Association of European Psychiatrists. 2001, 16: 274-282. [Review] [62 refs]
    https://doi.org/10.1016/S0924-9338(01)00578-8
80. Rounsaville BJ, Kranzler HR, Ball S, Tennen H, Poling J, Triffleman E: Personality disorders in substance abusers: relation to substance use. Journal of Nervous & Mental Disease. 1998, 186: 87-95.
    https://doi.org/10.1097/00005053-199802000-00004
81. Bakken K, Landheim AS, Vaglum P: Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?. Alcohol & Alcoholism. 2003, 38: 54-59.
    https://doi.org/10.1093/alcalc/agg012
82. Conigrave KM, Hall WD, Saunders JB: The AUDIT questionnaire: choosing a cut-off score. Alcohol Use Disorder Identification Test. Addiction. 1995, 90: 1349-1356. 10.1111/j.1360-0443.1995.tb03552.x.
    https://doi.org/10.1111/j.1360-0443.1995.tb03552.x
83. Dybek I, Bischof G, Grothues J, Reinhardt S, Meyer C, Hapke U, John U, Broocks A, Hohagen F, Rumpf HJ: The reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample. J Stud Alcohol. 2006, 67: 473-481.
    https://doi.org/10.15288/jsa.2006.67.473
84. Selin KH: Alcohol Use Disorder Identification Test (AUDIT): what does it screen? Performance of the AUDIT against four different criteria in a Swedish population sample. Subst Use Misuse. 2006, 41: 1881-1899. 10.1080/10826080601025532.
    https://doi.org/10.1080/10826080601025532
85. Berman AH, Bergman H, Palmstierna T, Schlyter F: Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005, 11: 22-31. 10.1159/000081413.
    https://doi.org/10.1159/000081413
86. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM: The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. 2001, 67: 45-59. 10.1016/S0165-0327(01)00432-3.
    https://doi.org/10.1016/S0165-0327(01)00432-3
87. Derogatis LR, Rickels K, Rock AF: The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976, 128: 280-289. 10.1192/bjp.128.3.280.
    https://doi.org/10.1192/bjp.128.3.280
88. Haver B: Screening for psychiatric comorbidity among female alcoholics: the use of a questionnaire (SCL-90) among women early in their treatment programme. Alcohol & Alcoholism. 1997, 32: 725-730.
    https://doi.org/10.1093/oxfordjournals.alcalc.a008322
89. Benjamin AB, Mossman D, Graves NS, Sanders RD: Tests of a symptom checklist to screen for comorbid psychiatric disorders in alcoholism. Compr Psychiatry. 2006, 47: 227-233. 10.1016/j.comppsych.2005.08.003.
    https://doi.org/10.1016/j.comppsych.2005.08.003
90. Vassend O, Skrondal A: The problem of structural indeterminacy in multidimensional symptom report instruments. The case of SCL-90-R. Behaviour Research & Therapy. 1999, 37: 685-701.
    https://doi.org/10.1016/S0005-7967(98)00182-X
91. Pedersen G, Hagtvet KA, Karterud S: Generalizability studies of the Global Assessment of Functioning-Split version. Compr Psychiatry. 2007, 48: 88-94. 10.1016/j.comppsych.2006.03.008.
    https://doi.org/10.1016/j.comppsych.2006.03.008
92. Vatnaland T, Vatnaland J, Friis S, Opjordsmoen S: Are GAF scores reliable in routine clinical use?. Acta Psychiatr Scand. 2007, 115: 326-330. 10.1111/j.1600-0447.2006.00925.x.
    https://doi.org/10.1111/j.1600-0447.2006.00925.x
93. Hasin D, Trautman K, Endicott J: Psychiatric research interview for substance and mental disorders: phenomenologically based diagnosis in patients who abuse alcohol or drugs. Psychopharmacol Bull. 1998, 34: 3-8.
    https://doi.org/10.1097/JCP.0000000000000075
94. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R: Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry. 2006, 163: 689-696. 10.1176/appi.ajp.163.4.689.
    https://doi.org/10.1176/appi.ajp.163.4.689
95. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1934, 59 (Suppl-33): [Review] [25 refs]
96. Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D, Namia C, Novella L, Petrachi M: Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. J Personal Disord. 1997, 11: 279-284.
    https://doi.org/10.1521/pedi.1997.11.3.279
97. Corruble E, Legrand JM, Duret C, Charles G, Guelfi JD: IDS-C and IDS-sr: psychometric properties in depressed in-patients. J Affect Disord. 1999, 56: 95-101. 10.1016/S0165-0327(99)00055-5.
    https://doi.org/10.1016/S0165-0327(99)00055-5
98. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C: The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res. 1986, 18: 65-87. 10.1016/0165-1781(86)90060-0.
    https://doi.org/10.1016/0165-1781(86)90060-0
99. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004, 34: 73-82. 10.1017/S0033291703001107.
    https://doi.org/10.1017/S0033291703001107
100. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979, 134: 382-389. 10.1192/bjp.134.4.382.
     https://doi.org/10.1192/bjp.134.4.382
101. Zimmerman M, Chelminski I, Posternak M: A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol. 2004, 19: 1-7. 10.1097/00004850-200401000-00001. [Review] [46 refs]
     https://doi.org/10.1097/00004850-200401000-00001
102. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978, 133: 429-435. 10.1192/bjp.133.5.429.
     https://doi.org/10.1192/bjp.133.5.429
103. Favre S, Aubry JM, Gex-Fabry M, Ragama-Pardos E, McQuillan A, Bertschy G: [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)]. Encephale. 2003, 29: 499-505. [French]
104. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, Skeppar P, Vieta E, Scott J: The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005, 88: 217-233. 10.1016/j.jad.2005.05.011.
     https://doi.org/10.1016/j.jad.2005.05.011
105. Benazzi F: Validating Angst's "ups & downs" personality trait as a new marker of bipolar II disorder. European Archives of Psychiatry & Clinical Neuroscience. 2004, 254: 48-54.
     https://doi.org/10.1007/s00406-004-0455-8

Which factors influence psychiatric diagnosing in substance abuse treatment?

Rolf Wynn, Anne Landheim, Ellen Hoxmark

https://doi.org/10.1186/1752-4458-7-17 · Full text

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms

Petra Amchova, Jana Kucerova, Valentina Giugliano, Zuzana Babinska, Mary T. Zanda, Maria Scherma, Ladislav Dusek, Paola Fadda, Vincenzo Micale, Alexandra Sulcova, Walter Fratta, Liana Fattore

https://doi.org/10.3389/fphar.2014.00044 · Full text

Current Trends and Perspectives in the Immune Therapy for Substance Use Disorders

Octavian Vasiliu

https://doi.org/10.3389/fpsyt.2022.882491 ·

Evaluation of Anxiety and Depression Among Female Spouses of Iranian Male Drug Dependents

Roya Noori, Firoozeh Jafari, Babak Moazen, Hamid Reza Khoddami Vishteh, Ali Farhoudian, Hooman Narenjiha, Hassan Rafiey

https://doi.org/10.5812/ijhrba.21624 · Full text

Presence of dual diagnosis between users and non-users of licit and illicit drugs in Brazil

Mariana Bandeira Formiga, Selene Cordeiro Vasconcelos, Melyssa Kellyane Cavalcanti Galdino, Murilo Duarte da Costa Lima

https://doi.org/10.1590/0047-2085000000091 · Full text

Multi-trait Analysis of GWAS (MTAG) of Substance Use Traits Identifies Novel Genetic Loci and Phenomic Associations

Heng Xu, Sylvanus Toikumo, Richard C. Crist, Klaudia Glogowska, Joseph D. Deak, Joel Gelernter, Emma C. Johnson, Henry R. Kranzler, Rachel L. Kember

https://doi.org/10.1101/2022.07.06.22277340

A Comparative Study of Psychopathological Profile Among Chronic Disease Patients: a Report from Health Centers in Malaysia

Tahereh Seghatoleslam, Abolfazl Ardakani, Hussain Habil, Rusdi Rashid, Monirsadat Mirzadeh

https://doi.org/10.1007/s11469-022-00852-8 ·

Assessment and Treatment of Patients with Comorbidity of Mental Health Problems and Alcohol Use Disorders: Experiences of Clinicians and Patients in the UK and Poland

Justyna Klingemann, Marta Welbel, Pablo Nicaise, Stefan Priebe, Aleksandra Matanov, Victoria Bird, Jacek Moskalewicz

https://doi.org/10.1093/alcalc/agz023 ·

Diagnostic capabilities of self-reported psychoactive substance use among patients admitted to psychiatric consultations in Benin, West Africa

Ahmat K. Abdelhakim, Assad Bio-Sya, Georgia Barikissou Damien, Elvyre T. E. Klikpo, G. M. Gansou, Aurel C. Allabi

https://doi.org/10.1186/s12888-022-04394-0 ·

Psychometric Characteristics of the Drug Use Disorders Identification Test (DUDIT) and the Drug Use Disorders Identification Test-Extended (DUDIT-E) Among Young Drug Users in Hungary

Balázs Matuszka, Erika Bácskai, Anne H. Berman, Pál Czobor, Kristina Sinadinovic, József Gerevich

https://doi.org/10.1007/s12529-013-9336-8 ·